Menu
Search
|

Menu

Close
X

Lantheus Holdings Inc LNTH.OQ (NASDAQ Stock Exchange Global Market)

20.55 USD
+0.20 (+0.98%)
As of Feb 16
chart
Previous Close 20.35
Open 20.25
Volume 43,521
3m Avg Volume 92,661
Today’s High 20.70
Today’s Low 20.25
52 Week High 24.45
52 Week Low 9.25
Shares Outstanding (mil) 37.35
Market Capitalization (mil) 677.92
Forward P/E 25.32
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY17
250
FY16
302
FY15
293
EPS (USD)
FY17
0.675
FY16
0.841
FY15
-0.974
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
25.32
32.90
Price to Sales (TTM)
vs sector
2.13
5.77
Price to Book (MRQ)
vs sector
--
5.41
Price to Cash Flow (TTM)
vs sector
13.83
23.42
Total Debt to Equity (MRQ)
vs sector
--
16.52
LT Debt to Equity (MRQ)
vs sector
--
12.22
Return on Investment (TTM)
vs sector
11.92
14.43
Return on Equity (TTM)
vs sector
--
16.13

EXECUTIVE LEADERSHIP

Brian Markison
Non-Executive Independent Chairman, Since 2013
Salary: --
Bonus: --
Mary Heino
President, Chief Executive Officer, Director, Since 2015
Salary: $600,000.00
Bonus: --
John Crowley
Chief Financial Officer, Treasurer, Since 2016
Salary: $340,308.00
Bonus: $50,000.00
Michael Duffy
Senior Vice President, Strategy and Business Development, General Counsel and Secretary, Since 2015
Salary: $380,039.00
Bonus: --
Timothy Healey
Senior Vice President, Commercial, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

331 Treble Cove Rd
NORTH BILLERICA   MA   01862-2849

Phone: +1978.6718001

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

SPONSORED STORIES